Joyce Nancy C, Harris Deshea L
Schepens Eye Research Institute and Department of Ophthalmology, Harvard Medical School, Boston, MA 02114, USA.
Mol Vis. 2010 May 25;16:897-906.
The current studies were conducted to determine whether the cyclin-dependent kinase inhibitors, p21Cip1 (p21 cyclin-dependent kinase-interacting protein 1) and p16INK4a (p16 cyclin-dependent kinase inhibitor 1A), help mediate G(1)-phase inhibition in human corneal endothelial cells (HCEC) by testing the effect of siRNA (small interfering RNA)-mediated down-regulation of the expression of these inhibitors on cell cycle entry and proliferation in HCEC cultured from older donors.
HCEC were obtained from National Disease Research Interchange, Philadelphia, PA, and cultured according to published methods. Cells were electroporated in the presence of either a non-silencing siRNA control or p21+p16 siRNA. The efficiency of siRNA transfer was observed by fluorescence microscopy of Cy3-labeled control siRNA. Viability was determined by direct counting of cells before and after electroporation. The ability of p21+p16 siRNA to decrease the protein expression of p21Cip1 and p16INK4a was determined by semi-quantitative analysis of western blots. The effect of siRNA treatment on cell cycle progression and proliferation was determined 1, 5, and 11 days after electroporation by counting Ki67-positive cells and total DAPI-stained nuclei.
siRNA was efficiently transferred to HCEC by the electroporation method. The average cell loss was 41.25% at 24 h following electroporation. Protein levels of both p21Cip1 and p16INK4a were significantly decreased as the result of p21+p16 siRNA treatment. This treatment significantly increased the average number of Ki67-positive cells over controls and increased the total number of cells in a time-dependent manner.
Both p21Cip1 and p16INK4a are involved in negative regulation of the cell cycle in HCEC and, thereby, provide an effective barrier to cell division. The siRNA-induced reduction in expression of these proteins increased the number of cells entering the cell cycle, as well as total cell numbers. Thus, reduction of the levels of p21Cip1 and p16INK4a could be useful in the development of treatments to induce transient cell division to increase corneal endothelial cell density.
进行当前研究以确定细胞周期蛋白依赖性激酶抑制剂p21Cip1(p21细胞周期蛋白依赖性激酶相互作用蛋白1)和p16INK4a(p16细胞周期蛋白依赖性激酶抑制剂1A)是否通过测试小干扰RNA(siRNA)介导的这些抑制剂表达下调对来自老年供体的人角膜内皮细胞(HCEC)细胞周期进入和增殖的影响,来帮助介导G1期抑制。
从宾夕法尼亚州费城的国家疾病研究交流中心获取HCEC,并按照已发表的方法进行培养。在存在非沉默siRNA对照或p21 + p16 siRNA的情况下对细胞进行电穿孔。通过Cy3标记的对照siRNA的荧光显微镜观察siRNA转移效率。通过电穿孔前后细胞的直接计数确定活力。通过蛋白质印迹的半定量分析确定p21 + p16 siRNA降低p21Cip1和p16INK4a蛋白表达的能力。在电穿孔后1、5和11天,通过计数Ki67阳性细胞和总DAPI染色核来确定siRNA处理对细胞周期进程和增殖的影响。
通过电穿孔方法将siRNA有效地转移到HCEC。电穿孔后24小时平均细胞损失率为41.25%。p21 + p16 siRNA处理导致p21Cip1和p16INK4a的蛋白水平均显著降低。这种处理显著增加了Ki67阳性细胞的平均数量,使其超过对照组,并以时间依赖性方式增加了细胞总数。
p21Cip1和p16INK4a均参与HCEC细胞周期的负调控,从而为细胞分裂提供有效屏障。siRNA诱导的这些蛋白质表达降低增加了进入细胞周期的细胞数量以及总细胞数量。因此,降低p21Cip1和p16INK4a的水平可能有助于开发诱导短暂细胞分裂以增加角膜内皮细胞密度的治疗方法。